Tag Archive for: STIMULAN

Biocomposites exceeds revenue expectations and takes a big step forward in its research and development collaboration with Swiss innovator CSEM

/in

New record for sales growth and number of patients supported Product portfolio enhanced through acquisition of NanoBone® and expansion of STIMULAN® approval as an antibiotic carrier to treat bacterial infection Research and Development boosts with STIMULAN VG moving to phase II clinical trial and investment in Renovite Keele, UK, 13 December 2023 – Biocomposites, an international […]

Read more

Biocomposites announces new territories approved to promote STIMULAN­® as an antibiotic carrier in bone and soft tissue

/in

Argentina and Taiwan added to list of approved territories STIMULAN gives surgeons the freedom to choose the antibiotics that support their infection treatment strategy Keele, UK, 11 October 2023 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased […]

Read more

STIMULAN® now available in South Africa to treat bacterial infection

/in

Novus Healthcare will exclusively distribute STIMULAN® and genex in South Africa Keele, UK, 10 May 2023 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces that its STIMULAN® products are now available in South Africa for treating bacterial […]

Read more

Biocomposites announce a year of record sales and company growth

/in

Winner of two Queen’s Awards for Enterprise in Innovation and International Trade Highest year-on-year sales growth in the company’s 25-year history Keele, UK, 14 December 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is celebrating its 25th anniversary […]

Read more

Biocomposites adds Mexico to its list of countries where STIMULAN is approved as an antibiotic carrier for use in bone and soft tissue

/in

STIMULAN® gives surgeons the freedom to choose and combine the antibiotics that support their infection treatment strategy Keele, UK, 29 November 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce that STIMULAN® has received a new […]

Read more